Broadway Financial Corporation ("Broadway") (NASDAQ: BYFC) and CFBanc Corporation ("City First") jointly announced today that they have received the regulatory approvals required to complete their proposed merger of equals transaction from the Office of the Comptroller of the Currency on December 24, 2020 and from the Federal Reserve Bank of San Francisco acting on behalf of the Board of Governors of the Federal Reserve System on December 28, 2020. Pursuant to the merger, City First will merge w...

Broadway Financial Corporation (the "Company") (The Nasdaq Stock Market LLC: BYFC), parent company of Broadway Federal Bank, f.s.b. (the "Bank"), today reported a net loss of $244 thousand, or ($0.01) per diluted share, for the third quarter of 2020, compared to a net loss of $279 thousand, or ($0.01) per diluted share, for the third quarter of 2019.

NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:Cancer Genetics, Inc.

WILMINGTON, Del., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Aimmune Therapeutics, Inc. (NASDAQ GS: AIMT) regarding possible breaches of fiduciary duties and other violations of law related to Aimmune’s agreement to be acquired by Sociétés des Produits Nestlé, S.A. Under the terms of the agreement, Aimmune’s shareholders will receive $34.50 in cash per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.co...

NEW YORK, NY / ACCESSWIRE / September 22, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:Proteostasis Therapeutics, Inc.

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Halper Sadeh LLP, a global investor rights law firm, is investigating:

Aimmune Therapeutics, Inc. (NASDAQ: AIMT)